Sadia Rahman
Stock Analyst at Wells Fargo
(2.51)
# 2,977
Out of 5,189 analysts
24
Total ratings
65%
Success rate
3.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sadia Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics | Rated: Buy | $55 | $31.37 | +75.33% | 7 | Nov 10, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | $135 | $84.55 | +59.67% | 8 | Nov 5, 2026 | |
| MDGL Madrigal Pharmaceuticals | Rated: Buy | $685 | $379.10 | +80.69% | 4 | Nov 4, 2026 | |
| VOR Vor Biopharma | Reiterated: Buy | $30 | $19.19 | +56.33% | 5 | Aug 31, 2026 |
Maze Therapeutics
Nov 10, 2026
Rated: Buy
Price Target: $55
Current: $31.37
Upside: +75.33%
Dianthus Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $135
Current: $84.55
Upside: +59.67%
Madrigal Pharmaceuticals
Nov 4, 2026
Rated: Buy
Price Target: $685
Current: $379.10
Upside: +80.69%
Vor Biopharma
Aug 31, 2026
Reiterated: Buy
Price Target: $30
Current: $19.19
Upside: +56.33%